PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control advanced prostate cancer
Disease control OngoingThis study tests niraparib combined with other drugs in men with metastatic castration-resistant prostate cancer that has spread and stopped responding to hormone therapy. The goal is to find safe, effective doses that can shrink tumors or lower cancer markers. 136 participants a…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Prostate cancer drug interaction study aims to improve safety
Knowledge-focused OngoingThis study looks at how the experimental drug JNJ-56021927 changes the way the body processes other common medications in men with castration-resistant prostate cancer. About 23 participants will take the study drug along with a cocktail of other drugs to measure how their levels…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE1 • Sponsor: Aragon Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 06:49 UTC
-
Cancer patients monitored for Long-Term side effects in safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows people with different cancers who have already received treatment in an earlier study. The main goal is to track serious side effects and other health issues over time. No new treatment is given; participants are simply monitored for safety.
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC